Showing results (1-10 of 815) with videos related to

Sort By:
Pageof 82
The Lancet. Psychiatry|March 10, 2019
Tapering of SSRI treatment to mitigate withdrawal symptomsMark Abie Horowitz, David Taylor
Addictive Behaviors|May 1, 2021
Should gabapentinoids be prescribed long-term for anxiety and other mental health conditions?Mark Abie Horowitz, Michael Kelleher, David Taylor
Therapeutic Advances in Psychopharmacology|November 3, 2025
Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptomsMark Abie Horowitz, Adele Framer, John Strang, et al.
Schizophrenia Bulletin|March 23, 2021
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of RelapseMark Abie Horowitz, Sameer Jauhar, Sridhar Natesan, et al.
CNS Drugs|December 13, 2022
Estimating Risk of Antidepressant Withdrawal from a Review of Published DataMark Abie Horowitz, Adele Framer, Michael P Hengartner, et al.
Schizophrenia (Heidelberg, Germany)|December 17, 2025
Helping people to discontinue antipsychotics: if, when and howJoanna Moncrieff, Mark Abie Horowitz
Therapeutic Advances in Psychopharmacology|July 17, 2020
Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorderJoanna Moncrieff, Swapnil Gupta, Mark Abie Horowitz
Journal of Psychiatric Research|March 29, 2023
Designing withdrawal support services for antidepressant users: Patients' views on existing services and what they really needJohn Read, Joanna Moncrieff, Mark Abie Horowitz
The International Journal of Neuropsychopharmacology|December 19, 2014
Antidepressant compounds can be both pro- and anti-inflammatory in human hippocampal cellsMark Abie Horowitz, Jasmin Wertz, Danhui Zhu, et al.
Pageof 82